|
Neonatal Intensive Care Drug Manual
|
| bet | 105/654 | | Sana | 03.01.2022 | | Hajmi | 1,5 Mb. | | #14803 |
Cephazolin
Revision Date : 16-12-2020
|
Approved: TC, KOH
|
Alert
|
High risk medicine. The Antimicrobial Stewardship Team recommends this drug is listed under the following category: Unrestricted.
Contains 48 mg of sodium per gram of cefazolin sodium.
|
Indication
|
Treatment of infections caused by susceptible organisms:
Gram positive bacteria Streptococci and Staphylococci including beta-lactamase producing Staphylococci
Gram negative bacteria Escherichia coli and some Klebsiella specie, provided these are reported susceptible to cefazolin).
|
Action
|
Bactericidal. Inhibits bacterial cell wall synthesis of actively dividing cells by binding to one or more penicillin binding proteins.
|
Drug type
|
Antibiotic, First generation cephalosporin.
|
Trade name
|
Cefazolin Sandoz, Cefazolin-AFT, Hospira Cefazolin, Kefzol, Cephazolin Alphapharm
|
|
|
| |
